Mammary Carcinoma Cell Derived Cyclooxygenase 2 Suppresses Tumor Immune Surveillance by Enhancing Intratumoral Immune Checkpoint Activity

INTRODUCTION: Systemic inhibition of the inflammatory enzyme cyclooxygenase (COX) 2 decreases the risk of breast cancer and its recurrence. However, the biology of COX-2 in the multicellular tumor microenvironment is poorly defined. METHODS: Mammary tumor onset and multiplicity were examined in ErbB...

Descripción completa

Detalles Bibliográficos
Autores principales: Markosyan, Nune, Chen, Edward P, Evans, Rebecca A, Ndong, Victoire, Vonderheide, Robert H, Smyth, Emer M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979159/
https://www.ncbi.nlm.nih.gov/pubmed/24004819
http://dx.doi.org/10.1186/bcr3469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979159/
https://www.ncbi.nlm.nih.gov/pubmed/24004819
http://dx.doi.org/10.1186/bcr3469

Ejemplares similares